Peptide antagonists of superantigen toxins

Molecular Diversity

Volumn 8, Issue 2, 2004, Pages 113-120

  Kaempfer, Raymond ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Antagonist peptides; Rational design; SEB; Superantigens; T cell activation; Toxic shock

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; PHENYLALANYLASPARTYLLYSYLLYSYLGLUTAMINYLLEUCYLALANYLISOLEUCYLSERYLTHREONYL LEUCYLASPARTIC ACID; PROTEIN INHIBITOR; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; THREONYLASPARAGINYLLYSYLLYSYLASPARAGINYLVALYLTHREONYLVALYLGLUTAMINYL GLUTAMYLLEUCYLASPARTIC ACID; THREONYLASPARAGINYLLYSYLLYSYLLYSYLVALYLTHREONYLALANYLGLUTAMINYLGLUTAMYL LEUCYLASPARTIC ACID; THREONYLASPARTYLLYSYLLYSYLMETHIONYLVALYLTHREONYLALANYLGLUTAMINYLGLUTAMYL LEUCYLASPARTIC ACID; TUMOR NECROSIS FACTOR; TYROSYLASPARAGINYLLYSYLLYSYLLYSYLALANYLTHREONYLVALYLGLUTAMINYLGLUTAMYL LEUCYLASPARTIC ACID; UNCLASSIFIED DRUG; VALYLGLUTAMINYLTYROSYLASPARAGINYLLYSYLLYSYLLYSYLALANYLTHREONYLVALYL GLUTAMINYLGLUTAMYLLEUCYLASPARTIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; EXPERIMENTAL MOUSE; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; SCREENING; SEPTIC SHOCK; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANIMALS; BACTERIAL TOXINS; CELLS, CULTURED; CYTOKINES; DRUG DESIGN; ENTEROTOXINS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; SHOCK, SEPTIC; STREPTOCOCCUS PYOGENES; STRUCTURAL HOMOLOGY, PROTEIN; SUPERANTIGENS; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3543010767     PISSN: 13811991     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MODI.0000025654.04427.44     Document Type: Article

References (38)

1. Scholl, P., Diez, A., Mourad, W., Parsonnet, J., Geha, R. S. and Chatila, T., Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules, Proc. Natl. Acad. Sci. USA, 86 (1989) 4210-1214.
2. Herman, A., Kappler, J. W., Marrack, P. and Pullen, A. M., Superantigens: Mechanisms of T-cell stimulation and role in immune responses, Ann. Rev. Immunol., 9 (1991) 745-772.
3. Fraser, J. D., High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR, Nature, 339 (1989) 221-223.
4. Choi, Y., Herman, A., DiGiusto, D., Wade, T., Marrack, P. and Kappler, J., Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens, Nature, 346 (1990) 471-473.
5. Kappler, J., Kotzin, B., Herron, L., Gelfand, E. W., Bigler, R. D., Boylston, A., Carrel, S., Posneit, C. D., Choi, Y. and Marrack, P., Vβ-specific stimulation of human T cells by staphylococcal toxins, Science, 244 (1989) 811-814.
6. Janeway, C. A., Yagi, J., Katz, M. E., Jones, B., Vregop, S. and Buxser, S., T Cell responses to MIs and to bacterial proteins that mimic its behavior, Immunol. Rev., 107 (1989) 61-68.
7. Choi, Y. W., Kotzin, B., Herren, L., Callahan, J., Marrack, P. and Kappler, J., Interaction of Staphylococcus aureus toxin 'superantigens' with human T cells, Proc. Natl. Acad. Sci. USA, 86 (1989) 8941-8945.
8. Bohach, G. A., Fast, D. J., Nelson, R. D. and Schlievert, P. M., Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses, Crit. Rev. Microbiol., 17 (1990) 251-272.
9. Kotzin, B. L., Leung, D. Y., Kappler, J. and Marrack, P., Superantigens and their potential role in human disease, Adv. Immunol., 54 (1993) 99-166.
10. McCormick, J. K., Yarwood, J. M. and Schlievert, P. M., Toxic shock syndrome and bacterial superantigens: An update, Annu. Rev. Microbiol., 55 (2001) 77-104.
11. Dinges, M. M., Orwin P. M. and Schlievert, P. M., Exotoxins of Staphylococcus aureus, Clin. Microbiol. Rev., 13 (2000) 16-34.
12. Proft, T., Moffatt, S. L., Berkahn, C. J. and Fraser, J. D., Identification and characterization of novel superantigens from Streptococcus pyogenes, J. Exp. Med., 189 (1999) 89-102.
13. McCormick, J. K., Pragman, A. A., Stolpa, J. C., Leung, D. Y. and Schlievert, P. M., Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen, Infect. Immun., 69 (2001) 1381-1388.
14. Smoot, L. M., McCormick, J. K., Smoot, J. C., Hoe, N. P., Strickland, I., Cole, R. L., Barbian, K. D., Earhart, C. A., Ohlendorf, D. H., Veasy, L. G., Hill, H. R., Leung, D. Y., Schlievert, P. M. and Musser, J. M., Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks, Infect. Immun., 70 (2002) 7095-7104.
15. Betley, M. J. and Mekalanos, J. J., Nucleotide sequence of the type A staphylococcal enterotoxin gene, J. Bacteriol., 170 (1988) 34-41.
16. Blomster-Hautamaa, D. A., Kreiswirth, B. N., Kornblum, J. S., Novick, R. P. and Schlievert, P. M., The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1, J. Biol. Chem., 261 (1986) 15783-15786.
17. Swaminathan, S., Furey, W., Pletcher, I. and Sax, M., Crystal structure of staphylococcal enterotoxin B, a superantigen, Nature, 359 (1992) 801-805.
18. Jardetzky, T. S., Brown, J. H., Gorga, J. C., Stern, L. J., Urban, R. G., Chi, Y. I., Stauffacher, C., Strominger, J. L. and Wiley, D. C., Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen, Nature, 368 (1994) 711-718.
19. Fields, B. A., Malchiodi, E. L., Li, H., Ysern, X., Stauffacher, C. V., Schlievert, P. M., Karjalainen, K. and Mariuzza, R. A., Crystal structure of a T-cell receptor beta-chain complexed with a superantigen, Nature, 384 (1996) 188-192.
20. Li, H., Llera, A., Tsuchiya, D., Leder, L., Ysern, X., Schlievert, P. M., Karjalainen, K. and Mariuzza, R. A., Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B, Immunity, 9 (1998) 807-816.
21. Papageorgiou, A. C., Tranter, H. S. and Acharya K. R., Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors, J. Mol. Biol., 277 (1998) 61-79.
22. Leder, L., Llera, A., Lavoie, P. M., Lebedeva, M. I., Li, H., Sekaly, R. P., Bohach, G. A., Gahr, P. J., Schlievert, P. M., Karjalainen, K. and Mariuzza, R. A., A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor β chain and major histocompatibility complex class II, J. Exp. Med., 187 (1998) 823-833.
23. Arad, G., Levy, R., Hillman, D. and Kaempfer, R., Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation, Nat. Med., 6 (2000) 414-421.
24. Arad, G., Hillman, D., Levy, R. and Kaempfer, R., Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock, J. Leukoc. Biol., 69 (2001) 921-927.
25. Gerez, L., Arad, G., Efrat, S., Ketzinel, M. and Kaempfer, R., Post-transcriptional regulation of human interleukin-2 gene expression at processing of precursor transcripts, J. Biol. Chem., 270 (1995) 19569-19575.
26. Arad, G., Tal, C., Ketzinel, M., Nussinovich, R., Deutsch, E., Schlesinger, M., Gerez, L. and Kaempfer, R., Transient expression of human IL-2 and IFN-γ genes is regulated by interaction between distinct cell subsets, Cell. Immunol., 160 (1995) 240-247.
27. Jarrous, N., Osman, F. and Kaempfer, R., 2-Aminopurine selectively inhibits splicing of tumor necrosis factor alpha mRNA, Mol. Cell. Biol., 16 (1996) 2814-2822.
28. Gerez, L., Madar, L., Arad, G., Sharav, T., Reshef, A., Ketzinel, M., Sayar, D., Silberberg, C. and Kaempfer, R., Aberrant regulation of interleukin-2 but not of interferon-γ gene expression in Down Syndrome (Trisomy 21), Clin. Immunol. Immunopathol., 58 (1991) 251-266.
29. Kaempfer, R., Gerez, L., Farbstein, H., Madar, L., Hirschman, O., Nussinovich, R. and Shapiro, A., Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression, J. Clin. Oncol., 14 (1996) 1778-1786.
30. Schad, E. M., Zaitseva, I., Zaitsev, V. N., Dohlsten, M., Kalland, T., Schlievert, P. M., Ohlendorf, D. H. and Svensson, L. A., Crystal structure of the superantigen staphylococcal enterotoxin type A, EMBO J., 14 (1995) 3292-3301.
31. Prasad, G. S., Earhart, C. A., Murray, D. L., Novick, R. P., Schlievert, P. M. and Ohlendorf, D. H., Structure of toxic shock syndrome toxin 1, Biochemistry, 32 (1993) 13761-13766.
32. Buelow, R., O'Hehir, R. E., Schreifels, R., Kummerehl, T. J., Riley, G. and Lamb, J. R., Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins, J. Immunol., 148 (1992) 1-6.
33. Kappler, J. W., Herman, A., Clements, J. and Marrack, P., Mutations defining functional regions of the superantigen staphylococcal enterotoxin B, J. Exp. Med., 175 (1992) 387-389.
34. Hoffmann, M. L., Jablonski, L. M., Crum, K. K., Hackett, S. P., Chi, Y. I., Stauffacher, C. V., Stevens, D. L. and Bohach, G. A., Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1, Infect. Immun., 62 (1994) 3396-3407.
35. Arcus, V. L., Proft, T., Sigrell, J. A., Baker, H. M., Fraser, J. D. and Baker, E. N., Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes, J. Mol. Biol., 299 (2000) 157-168.
36. Li, H., Llera, A. and Mariuzza, R. A., Structure-function studies of T-cell receptor-superantigen interactions, Immunol. Rev., 163 (1998) 177-186.
37. Sundberg, E. J., Li, H., Llera, A. S., McCormick, J. K., Tormo, J., Schlievert, P. M., Karjalainen, K. and Mariuzza, R. A., Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes, Structure, 10 (2002) 687-699.
38. Sundberg, E. J., Li, Y. and Mariuzza, R. A., So many ways of getting in the way: Diversity in the molecular architecture of superantigen-dependent T-cell signaling complexes, Curr. Opin. Immunol., 14 (2002) 36-44.